LeWitt P A
Clinical Neuroscience Program, Sinai Hospital, Detroit, Michigan.
Neurology. 1993 Dec;43(12 Suppl 6):S31-7.
Even though levodopa can provide effective therapy for symptomatic relief of parkinsonism, many patients deteriorate over time. This change may be related to a loss of storage capability for dopamine in the brain affected by parkinsonian changes. Some of the variability in drug action is determined by its peripheral pharmacokinetics. Methods that can enhance dose-by-dose effectiveness, including controlled-release preparations and enteral infusions, have practical applications for managing "wearing-off" or peak-effect problems.
尽管左旋多巴可为帕金森病的症状缓解提供有效的治疗方法,但许多患者会随着时间的推移而病情恶化。这种变化可能与受帕金森病改变影响的大脑中多巴胺储存能力的丧失有关。药物作用的一些变异性由其外周药代动力学决定。能够提高逐剂量疗效的方法,包括控释制剂和肠内输注,在处理“疗效减退”或峰值效应问题方面具有实际应用价值。